Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AKAO Insider Trading

AKAO | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at AKAO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-03-21 00:24 2019-03-18 DUGGAN ROBERT W 10% owner SELL $0.54 1,277,888 $685,459 5,555,414 -18.7%
2019-03-14 00:31 2019-03-11 DUGGAN ROBERT W 10% owner SELL $0.60 2,354,007 $1,422,291 6,833,302 -25.6%
2019-02-26 04:45 2019-02-21 Bhatt Elizabeth Officer - Chief Operating Officer SELL $0.89 971 $864 238,155 -0.4%
2019-02-26 04:44 2019-02-21 Dorling Janet Officer - Chief Commercial Officer SELL $0.89 1,063 $946 284,738 -0.4%
2019-02-26 04:43 2019-02-21 Sarpangal Zeryn Officer - Chief Financial Officer SELL $0.89 1,388 $1,235 242,546 -0.6%
2019-02-26 04:42 2019-02-21 LOEB GARY Officer - See Remarks SELL $0.89 791 $704 239,673 -0.3%
2019-02-26 04:41 2019-02-21 Wise Blake Officer - Chief Executive Officer SELL $0.89 3,771 $3,356 505,650 -0.7%
2019-02-08 04:00 2019-02-05 Dorling Janet Officer - Chief Commercial Officer SELL $1.35 818 $1,104 285,801 -0.3%
2018-12-13 02:23 2018-12-10 DUGGAN ROBERT W 10% owner BUY $1.62 743,348 $1,202,811 9,187,309 +8.8%
2018-12-12 01:44 2018-12-07 DUGGAN ROBERT W 10% owner BUY $1.40 22,431 $31,394 8,443,961 +0.3%
2018-11-28 01:22 2018-11-23 DUGGAN ROBERT W 10% owner BUY $1.79 157,760 $281,602 8,421,530 +1.9%
2018-11-23 21:45 2018-11-20 DUGGAN ROBERT W 10% owner BUY $1.93 231,495 $446,947 8,263,770 +2.9%
2018-11-21 00:08 2018-11-19 DUGGAN ROBERT W 10% owner BUY $1.62 4,648 $7,525 8,032,275 +0.1%
2018-09-28 03:08 2018-09-25 LOEB GARY Officer - General Counsel SELL $4.15 1,038 $4,308 22,831 -4.3%
2018-09-28 03:07 2018-09-25 Wise Blake Officer - Chief Operating Officer SELL $4.15 3,242 $13,454 92,721 -3.4%
2018-06-28 23:21 2018-06-26 Wise Blake Director, Officer - Chief Executive Officer SELL $9.59 1,194 $11,450 95,963 -1.2%
2018-06-28 23:20 2018-06-26 Schilke Tobin Officer - Chief Financial Officer SELL $9.59 298 $2,858 47,748 -0.6%
2018-06-28 23:20 2018-06-26 LOEB GARY Officer - General Counsel SELL $9.59 324 $3,107 23,869 -1.3%
2018-06-28 23:19 2018-06-26 Hillan Kenneth J. Director, Officer - See Remarks SELL $9.59 744 $7,135 115,401 -0.6%
2018-06-28 23:18 2018-06-26 Dorling Janet Officer - Chief Commercial Officer SELL $9.59 450 $4,316 23,819 -1.9%
2018-06-14 00:03 2018-06-11 Schilke Tobin Officer - Chief Financial Officer SELL $11.95 2,087 $24,940 47,186 -4.2%
2018-05-16 01:31 2017-09-25 Swem Lee Officer - Chief Scientific Officer SELL $15.99 900 $14,391 35,919 -2.4%
2018-05-08 00:54 2018-05-03 DUGGAN ROBERT W 10% owner BUY $11.33 976,880 $11,072,153 100,255 +100.0%
2018-04-28 01:30 2018-04-25 DUGGAN ROBERT W 10% owner BUY $12.98 230,096 $2,986,853 7,181,002 +3.3%
2018-04-24 01:50 2018-04-19 DUGGAN ROBERT W 10% owner BUY $13.06 468,337 $6,118,636 6,950,906 +7.2%
2018-04-05 04:25 2018-04-02 DUGGAN ROBERT W 10% owner BUY $12.46 91,461 $1,139,421 6,482,569 +1.4%
2018-03-31 02:18 2018-03-28 DUGGAN ROBERT W 10% owner BUY $12.44 30,000 $373,095 6,391,108 +0.5%
2018-03-22 01:39 2018-03-19 DUGGAN ROBERT W 10% owner BUY $11.12 36,300 $403,710 6,361,108 +0.6%
2018-03-17 00:04 2018-03-14 DUGGAN ROBERT W 10% owner BUY $11.36 49,660 $564,242 6,324,808 +0.8%
2018-03-16 02:17 2018-03-13 Hillan Kenneth J. Director, Officer - See Remarks SELL $11.74 2,735 $32,109 95,151 -2.8%
2018-03-14 01:38 2018-03-09 DUGGAN ROBERT W 10% owner BUY $11.40 70,000 $798,322 6,275,148 +1.1%
2018-03-03 02:44 2018-02-28 DUGGAN ROBERT W 10% owner BUY $10.31 527,396 $5,438,877 6,205,148 +9.3%
2018-02-24 04:39 2018-02-21 Wise Blake Director, Officer - Chief Executive Officer SELL $10.67 1,640 $17,499 65,645 -2.4%
2018-02-24 04:38 2018-02-21 Swem Lee Officer - Chief Scientific Officer SELL $10.67 1,282 $13,679 36,819 -3.4%
2018-02-24 04:38 2018-02-21 Schilke Tobin Officer - Chief Financial Officer SELL $10.67 1,108 $11,822 40,185 -2.7%
2018-02-24 04:37 2018-02-21 Hillan Kenneth J. Director, Officer - See Remarks SELL $10.67 4,606 $49,146 97,886 -4.5%
2018-02-16 01:43 2018-02-13 DUGGAN ROBERT W 10% owner BUY $10.96 10,000 $109,606 5,677,752 +0.2%
2018-01-06 02:03 2018-01-03 DUGGAN ROBERT W 10% owner BUY $11.37 65,000 $738,855 5,667,752 +1.2%
2017-12-21 02:07 2017-12-18 DUGGAN ROBERT W 10% owner BUY $11.13 95,012 $1,057,493 5,602,752 +1.7%
2017-09-29 01:00 2017-09-26 Wise Blake Officer - President & COO SELL $15.99 3,576 $57,180 66,111 -5.1%
2017-09-29 01:00 2017-09-26 LOEB GARY Officer - General Counsel SELL $15.99 1,146 $18,325 13,333 -7.9%
2017-06-15 02:39 2017-06-12 Schilke Tobin Officer - Chief Financial Officer SELL $21.53 2,066 $44,481 40,119 -4.9%
2017-03-17 02:45 2017-03-14 Hillan Kenneth J. Director, Officer - Chief Executive Officer SELL $26.58 3,079 $81,840 98,422 -3.0%
2017-02-24 03:40 2017-02-21 Friedland Ian Officer - SVP, Chief Medical Officer SELL $22.76 1,026 $23,352 37,007 -2.7%
2017-02-24 03:39 2017-02-21 Sarpangal Zeryn Officer - See Remarks SELL $22.76 439 $9,992 16,522 -2.6%
2017-02-24 03:39 2017-02-21 Hillan Kenneth J. Director, Officer - Chief Executive Officer SELL $22.76 1,696 $38,601 61,501 -2.7%
2017-01-31 05:39 2017-01-26 Wise Blake Officer - Chief Operating Officer SELL $16.78 1,431 $24,012 46,687 -3.0%
2017-01-31 05:38 2017-01-26 Schilke Tobin Officer - Chief Financial Officer SELL $16.78 955 $16,025 26,045 -3.5%
2017-01-31 05:37 2017-01-26 LOEB GARY Officer - General Counsel SELL $16.78 521 $8,742 14,479 -3.5%
2017-01-31 05:37 2017-01-26 Sarpangal Zeryn Officer - VP, HR and Corporate Affairs SELL $16.78 781 $13,105 16,961 -4.4%
SHOW ENTRIES
1-50 OF 67

How to Interpret $AKAO Trades

Not every insider transaction in AKAO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AKAO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AKAO

Insider activity data for AKAO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AKAO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.